Cargando…
Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma
Metastatic renal cell carcinoma with sarcomatoid histology (SmRCC) is associated with poor survival. No data is available from randomized trials on the efficacy of vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) inhibitors in SmRCC. We identified SmRCC patients fro...
Autores principales: | Tantravahi, Srinivas K., Albertson, Daniel, Agarwal, Archana M., Ravulapati, Sowmya, Poole, Austin, Patel, Shiven B., Hawatmeh, Jamil S., Straubhar, Alli M., Liu, Ting, Stenehjem, David D., Agarwal, Neeraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320862/ https://www.ncbi.nlm.nih.gov/pubmed/25688268 http://dx.doi.org/10.1155/2015/181926 |
Ejemplares similares
-
Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma
por: Kuzman, James A., et al.
Publicado: (2017) -
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2
por: Gill, David M, et al.
Publicado: (2016) -
Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma
por: Stenehjem, David D., et al.
Publicado: (2019) -
Margin status in vulvovaginal melanoma: Management and oncologic outcomes of 50 cases
por: Straubhar, Alli M., et al.
Publicado: (2023) -
Successful treatment of low-grade endometrial cancer in premenopausal women with an aromatase inhibitor after failure with oral or intrauterine progesterone
por: Straubhar, Alli, et al.
Publicado: (2017)